180 related articles for article (PubMed ID: 35504869)
1. MrgprF acts as a tumor suppressor in cutaneous melanoma by restraining PI3K/Akt signaling.
Shen Q; Han Y; Wu K; He Y; Jiang X; Liu P; Xia C; Xiong Q; Liu R; Chen Q; Zhang Y; Zhao S; Yang C; Chen Y
Signal Transduct Target Ther; 2022 May; 7(1):147. PubMed ID: 35504869
[TBL] [Abstract][Full Text] [Related]
2. BRAFV600E cooperates with PI3K signaling, independent of AKT, to regulate melanoma cell proliferation.
Silva JM; Bulman C; McMahon M
Mol Cancer Res; 2014 Mar; 12(3):447-63. PubMed ID: 24425783
[TBL] [Abstract][Full Text] [Related]
3. STAT3-induced upregulation of lncRNA SNHG17 predicts a poor prognosis of melanoma and promotes cell proliferation and metastasis through regulating PI3K-AKT pathway.
Gao H; Liu R; Sun X
Eur Rev Med Pharmacol Sci; 2019 Sep; 23(18):8000-8010. PubMed ID: 31599425
[TBL] [Abstract][Full Text] [Related]
4. Phosphatidylinositol Phosphate 5-Kinase Iγ and Phosphoinositide 3-Kinase/Akt Signaling Couple to Promote Oncogenic Growth.
Thapa N; Choi S; Tan X; Wise T; Anderson RA
J Biol Chem; 2015 Jul; 290(30):18843-54. PubMed ID: 26070568
[TBL] [Abstract][Full Text] [Related]
5. Downregulation of lncRNA H19 inhibits the migration and invasion of melanoma cells by inactivating the NF‑κB and PI3K/Akt signaling pathways.
Liao Z; Zhao J; Yang Y
Mol Med Rep; 2018 May; 17(5):7313-7318. PubMed ID: 29568965
[TBL] [Abstract][Full Text] [Related]
6. FOXC1 promotes melanoma by activating MST1R/PI3K/AKT.
Wang J; Li L; Liu S; Zhao Y; Wang L; Du G
Oncotarget; 2016 Dec; 7(51):84375-84387. PubMed ID: 27533251
[TBL] [Abstract][Full Text] [Related]
7. lncRNA EZR‑AS1 knockdown represses proliferation, migration and invasion of cSCC via the PI3K/AKT signaling pathway.
Lu D; Sun L; Li Z; Mu Z
Mol Med Rep; 2021 Jan; 23(1):. PubMed ID: 33236153
[TBL] [Abstract][Full Text] [Related]
8. Role of EIF5A2, a downstream target of Akt, in promoting melanoma cell invasion.
Khosravi S; Wong RP; Ardekani GS; Zhang G; Martinka M; Ong CJ; Li G
Br J Cancer; 2014 Jan; 110(2):399-408. PubMed ID: 24178756
[TBL] [Abstract][Full Text] [Related]
9. Phosphoinositide-Binding Protein TIPE1 Promotes Alternative Activation of Macrophages and Tumor Progression via PIP3/Akt/TGFβ Axis.
Cheng Y; Bai F; Ren X; Sun R; Guo X; Liu W; Wang B; Yang Y; Zhang X; Xu Y; Li C; Yang X; Gao L; Ma C; Li X; Liang X
Cancer Res; 2022 Apr; 82(8):1603-1616. PubMed ID: 35135809
[TBL] [Abstract][Full Text] [Related]
10. RhoC promotes human melanoma invasion in a PI3K/Akt-dependent pathway.
Ruth MC; Xu Y; Maxwell IH; Ahn NG; Norris DA; Shellman YG
J Invest Dermatol; 2006 Apr; 126(4):862-8. PubMed ID: 16470169
[TBL] [Abstract][Full Text] [Related]
11. Inhibition of spindle and kinetochore associated complex subunit 3 suppresses the proliferation and invasion and induced the apoptosis of cutaneous melanoma by affecting the PI3K/Akt pathway.
Liang Y; Zheng Y; Mou K; Han D; Wang L; Ge R; Meng A
J Biochem Mol Toxicol; 2021 Nov; 35(11):e22895. PubMed ID: 34423490
[TBL] [Abstract][Full Text] [Related]
12. Embryonic stem cell microenvironment suppresses the malignancy of cutaneous melanoma cells by down-regulating PI3K/AKT pathway.
Wang C; Wang X; Liu J; Huang Z; Li C; Liu Y; Sang X; Yang L; Wang S; Su Y; Liu C; Liu Y; Wang Z
Cancer Med; 2019 Aug; 8(9):4265-4277. PubMed ID: 31173492
[TBL] [Abstract][Full Text] [Related]
13. PI(4,5)P2 5-phosphatase A regulates PI3K/Akt signalling and has a tumour suppressive role in human melanoma.
Ye Y; Jin L; Wilmott JS; Hu WL; Yosufi B; Thorne RF; Liu T; Rizos H; Yan XG; Dong L; Tay KH; Tseng HY; Guo ST; de Bock CE; Jiang CC; Wang CY; Wu M; Zhang LJ; Hersey P; Scolyer RA; Zhang XD
Nat Commun; 2013; 4():1508. PubMed ID: 23443536
[TBL] [Abstract][Full Text] [Related]
14. Basal and treatment-induced activation of AKT mediates resistance to cell death by AZD6244 (ARRY-142886) in Braf-mutant human cutaneous melanoma cells.
Gopal YN; Deng W; Woodman SE; Komurov K; Ram P; Smith PD; Davies MA
Cancer Res; 2010 Nov; 70(21):8736-47. PubMed ID: 20959481
[TBL] [Abstract][Full Text] [Related]
15. Lucidone Promotes the Cutaneous Wound Healing Process via Activation of the PI
Yang HL; Tsai YC; Korivi M; Chang CT; Hseu YC
Biochim Biophys Acta Mol Cell Res; 2017 Jan; 1864(1):151-168. PubMed ID: 27816443
[TBL] [Abstract][Full Text] [Related]
16. MCM7 silencing promotes cutaneous melanoma cell autophagy and apoptosis by inactivating the AKT1/mTOR signaling pathway.
Yang Y; Ma S; Ye Z; Zhou X
J Cell Biochem; 2020 Feb; 121(2):1283-1294. PubMed ID: 31535400
[TBL] [Abstract][Full Text] [Related]
17. Knockdown of NLE1 inhibits development of malignant melanoma in vitro and in vivo NLE1 promotes development of malignant melanoma.
Ren Z; Ni F; Zhang T; Yuan X; Li J; Xiao W
Exp Cell Res; 2021 Jul; 404(2):112636. PubMed ID: 34019907
[TBL] [Abstract][Full Text] [Related]
18. Macrophage migration inhibitory factor engages PI3K/Akt signalling and is a prognostic factor in metastatic melanoma.
Oliveira CS; de Bock CE; Molloy TJ; Sadeqzadeh E; Geng XY; Hersey P; Zhang XD; Thorne RF
BMC Cancer; 2014 Aug; 14():630. PubMed ID: 25168062
[TBL] [Abstract][Full Text] [Related]
19. Knockdown of TRIM47 inhibits breast cancer tumorigenesis and progression through the inactivation of PI3K/Akt pathway.
Wang Y; Liu C; Xie Z; Lu H
Chem Biol Interact; 2020 Feb; 317():108960. PubMed ID: 31981573
[TBL] [Abstract][Full Text] [Related]
20. Glutaminase 2 negatively regulates the PI3K/AKT signaling and shows tumor suppression activity in human hepatocellular carcinoma.
Liu J; Zhang C; Lin M; Zhu W; Liang Y; Hong X; Zhao Y; Young KH; Hu W; Feng Z
Oncotarget; 2014 May; 5(9):2635-47. PubMed ID: 24797434
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
